The standard view of this forum does not always work well with assistive technology. We also provide a simpler view, which still contains all features. Switch to simple view.
Allison Worth

Allison Worth Post 1

• 19 January 2016, 12:36 PM

Patient involvement: the pharma perspective

Hello everyone

I'll be mentioning EUPATI in the lecture tomorrow - you might be interested in this newly published paper which looks at the views of people who work in pharma about patient and public involvement:

Suzanne Parsons, Bella Starling, Christine Mullan-Jensen, Su-Gwan Tham, Kay Warner, Kim Wever. What do pharmaceutical industry professionals in Europe believe about involving patients and the public in research and development of medicines? A qualitative interview study. BMJ Open 2016. (http://bmjopen.bmj.com/content/6/1/e008928.full?sid=e9547d90-0de6-4078-ae92-7dc3ab76d742)

Happy reading!

Allison

 

Valeria Kovacs

Valeria Kovacs Post 2 in reply to 1

• 19 January 2016, 7:26 PM

to Allison: PPI & Pharma

Thanks Allison for this paper, I am so looking forward to reading it!

Just to let you know that EUPATI platform Switzerland launches on 3 February 2016 and at the moment we have only two patient representatives being trained smile

long way to go...

KR
Valeria